Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization

Cardiovasc Pathol. 2020 Sep-Oct:48:107223. doi: 10.1016/j.carpath.2020.107223. Epub 2020 Apr 28.

Abstract

Saprochaete species infection is a rare fungal disease reported so far only in immunocompromised patients. We describe the first case of aortitis caused by Saprochaete capitata, presenting as ascending aorta aneurysm, with secondary endophthalmitis in an immunocompetent patient. Infection by Saprochaete capitata is potentially fatal, with a mortality ranging from 50% to 90% of cases. In the present case aortic aneurysm caused by Saprochaete capitata aortitis was successfully treated by the combination of accurate diagnosis with surgical and specific antifungal therapy.

Keywords: Aortitis; Mycotic endophthalmitis; Saprochaete capitata.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aneurysm, Infected / diagnosis
  • Aneurysm, Infected / immunology
  • Aneurysm, Infected / microbiology*
  • Aneurysm, Infected / therapy
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Aneurysm / diagnosis
  • Aortic Aneurysm / immunology
  • Aortic Aneurysm / microbiology*
  • Aortic Aneurysm / therapy
  • Aortitis / diagnosis
  • Aortitis / immunology
  • Aortitis / microbiology*
  • Aortitis / therapy
  • Blood Vessel Prosthesis Implantation
  • Humans
  • Immunocompetence*
  • Invasive Fungal Infections / diagnosis
  • Invasive Fungal Infections / immunology
  • Invasive Fungal Infections / microbiology*
  • Invasive Fungal Infections / therapy
  • Male
  • Myocardial Revascularization / adverse effects*
  • Saccharomycetales / drug effects
  • Saccharomycetales / immunology
  • Saccharomycetales / isolation & purification*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents